Prostaglandins E

DBCAT001121Pharmacologic class

(11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. A DrugBank category of 9 drugs. 4 of them are approved.

Also known as: PGE · E, Prostaglandins
Drugs: Alprostadil
Dinoprostone
Enisoprost
Gemeprost
Limaprost
Lubiprostone
Ornoprostil
Sulprostone
Trimoprostil

What you can answer from here — as of August 24, 2016

9DrugsEach linked to its full drug card

Listed above

9Drug targetsEvery drug–target pair in the class, with bond type

259Marketed productsAcross the regions we cover, with dosage forms and routes

11Routes of administrationHow the drugs in this class are given

Which targets do Prostaglandins E share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account